Medical System Network Grows Sales but Faces Profit Pressure in Q3 FY2026

Medical System Network Co., Ltd. ( (JP:4350) ) has provided an announcement.

Medical System Network Co., Ltd. reported that its pharmacy support businesses, including the pharmaceutical network, are steadily expanding, with a growing number of pharmacies using its services and new community pharmacies opened in the previous term beginning to contribute. The company also saw a steady build-out of business partners in its pharmaceutical manufacturing, sales, and logistics divisions, but operating profit declined despite a 7.4% year-on-year rise in net sales to 98.68 billion yen, as higher personnel costs and fewer patients with acute illnesses weighed on margins.

While influenza was prevalent during the period, the overall number of acute illness cases was significantly lower than a year earlier, reducing prescription volumes and impacting profitability in its pharmacy operations. At the end of the third quarter, net sales had reached 78.6% of the full-year forecast and operating profit 69.8%, indicating solid top-line progress but pressure on earnings, which may influence how investors assess the company’s efficiency and cost management going into the fiscal year-end.

The most recent analyst rating on (JP:4350) stock is a Buy with a Yen580.00 price target. To see the full list of analyst forecasts on Medical System Network Co., Ltd. stock, see the JP:4350 Stock Forecast page.

More about Medical System Network Co., Ltd.

Medical System Network Co., Ltd. operates in the healthcare sector, focusing on pharmacy support services and community pharmacy operations. The company also runs pharmaceutical network, manufacturing and sales, and logistics divisions, aiming to expand its partner base and support pharmacies nationwide.

Average Trading Volume: 34,698

Technical Sentiment Signal: Buy

Current Market Cap: Yen15.81B

Find detailed analytics on 4350 stock on TipRanks’ Stock Analysis page.